SAN JOSE, Calif.--(BUSINESS WIRE)--HemoSense, Inc. (AMEX:HEM) – a medical device company that develops, manufactures and sells easy-to-use, handheld blood coagulation monitoring systems for use by patients and healthcare professionals in the management of warfarin medication – today reported financial results for the first quarter of fiscal year 2007, ended December 31, 2006.
